Profilo
David Sandoval currently serves as Chief Compliance Officer & General Counsel at Milestone Pharmaceuticals, Inc. since 2026.
Memberships include the New York State Bar Association and the New Jersey State Bar Association.
Former roles include Senior VP-Legal & Deputy General Counsel at MaxCyte, Inc. from 2023 to 2024, Chief Legal & Compliance Officer at Leadiant Biosciences, Inc. from 2010 to 2023, and Assistant General Counsel at Enzon Pharmaceuticals, Inc. from 2007 to 2010.
Education includes graduate studies at New York University School of Law and undergraduate studies at Cornell University.
Posizioni attive di David Sandoval
| Società | Posizione | Inizio |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Responsabile della Conformità | 10/02/2026 |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
New Jersey State Bar Association
New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Corporate Officer/Principal | - |
Precedenti posizioni note di David Sandoval
| Società | Posizione | Fine |
|---|---|---|
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Responsabile della Conformità | 01/11/2023 |
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Corporate Officer/Principal | 01/01/2010 |
| MAXCYTE, INC. | Consigliere Generale | - |
Formazione di David Sandoval
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative therapeutics for cancer patients | Health Technology |
MaxCyte, Inc.
MaxCyte, Inc. BiotechnologyHealth Technology Specializes in cell modification technologies to enable the discovery, development, manufacturing, and delivery of therapeutic products | Health Technology |
Milestone Pharmaceuticals, Inc.
Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel medicines for rare diseases | Health Technology |
New York State Bar Association
New York State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New Jersey State Bar Association
New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services Operates as a bar association | Commercial Services |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















